Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No substantive changes to content or features.
    Difference
    0.1%
    Check dated 2026-04-19T12:47:06.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; previous revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T08:37:55.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page shows a revision from v3.4.2 to v3.4.3. This appears to be a minor update with no changes to study content.
    Difference
    0.1%
    Check dated 2026-03-06T18:42:56.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Site-level revision notes show Revision: v3.4.2 with dates 2026-01-26 and 2026-02-12, replacing v3.4.1; this does not affect the study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T12:38:31.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No visible changes to study content or navigation.
    Difference
    0.1%
    Check dated 2026-02-05T17:19:47.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 and has removed Revision: v3.3.3, a minor metadata update that does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:03:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.